VivoSim Labs, Inc. Cost of Revenue
VivoSim Labs, Inc. (VIVS) reported Cost of Revenue of $0 for the 12-month period ending 2021-03-31, per its 10-K filed 2021-06-15.
Discontinued › Expense Statement › Cost of Sales
us-gaap:CostOfRevenue · last filed 2021-06-15
- VivoSim Labs, Inc. cost of revenue for the quarter ending 2021-03-31 was $0.00.
- VivoSim Labs, Inc. cost of revenue for the quarter ending 2020-12-31 was $0.00.
- VivoSim Labs, Inc. cost of revenue for the quarter ending 2020-09-30 was $0.00, a 100.00% decline year-over-year.
- VivoSim Labs, Inc. cost of revenue for the quarter ending 2020-06-30 was $0.00, a 100.00% decline year-over-year.
- VivoSim Labs, Inc. cost of revenue for fiscal 2021 was $0.00, a 100.00% decline from fiscal 2020.
- VivoSim Labs, Inc. cost of revenue for fiscal 2020 was $300.00K, a 40.00% decline from fiscal 2019.
- VivoSim Labs, Inc. cost of revenue for fiscal 2019 was $500.00K, a 50.00% decline from fiscal 2018.
- VivoSim Labs, Inc. cost of revenue for fiscal 2018 was $1.00M, a 4.60% increase from fiscal 2017.
| Period end | Cost of Revenue 3 month | Cost of Revenue 3 month as first filed | Cost of Revenue 6 month | Cost of Revenue 6 month as first filed | Cost of Revenue 9 month | Cost of Revenue 9 month as first filed | Cost of Revenue 12 month | Cost of Revenue 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2021-03-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-06-15 | $0.00 derived: sum of 2 quarters · filed 2021-06-15 | $0.00 derived: sum of 3 quarters · filed 2021-06-15 | $0.00 10-K · filed 2021-06-15 | ||||
| 2020-12-31 | $0.00 10-Q · filed 2021-02-08 | $0.00 derived: sum of 2 quarters · filed 2021-02-08 | $0.00 10-Q · filed 2021-02-08 | $0.00 derived: sum of 4 quarters · filed 2021-06-15 | ||||
| 2020-09-30 | $0.00 10-Q · filed 2020-11-05 | $0.00 10-Q · filed 2020-11-05 | $0.00 derived: sum of 3 quarters · filed 2021-06-15 | $0.00 derived: sum of 4 quarters · filed 2021-06-15 | ||||
| 2020-06-30 | $0.00 10-Q · filed 2020-08-10 | $0.00 derived: sum of 2 quarters · filed 2021-06-15 | $0.00 derived: sum of 3 quarters · filed 2021-06-15 | $300.00K derived: sum of 4 quarters · filed 2021-06-15 | ||||
| 2020-03-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-06-15 | $0.00 derived: sum of 2 quarters · filed 2021-06-15 | $300.00K derived: sum of 3 quarters · filed 2021-06-15 | $300.00K 10-K · filed 2021-06-15 | ||||
| 2019-12-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-02-08 | $300.00K derived: sum of 2 quarters · filed 2021-02-08 | $300.00K 10-Q · filed 2021-02-08 | $500.00K derived: sum of 4 quarters · filed 2021-02-08 | ||||
| 2019-09-30 | $300.00K 10-Q · filed 2020-11-05 | $300.00K 10-Q · filed 2020-11-05 | $500.00K derived: sum of 3 quarters · filed 2020-11-05 | $600.00K derived: sum of 4 quarters · filed 2020-11-05 | ||||
| 2019-06-30 | $100.00K 10-Q · filed 2020-08-10 | $200.00K derived: sum of 2 quarters · filed 2020-08-10 | $300.00K derived: sum of 3 quarters · filed 2020-08-10 | $400.00K derived: sum of 4 quarters · filed 2020-08-10 | ||||
| 2019-03-31 | $100.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-05-28 | $200.00K derived: sum of 2 quarters · filed 2020-05-28 | $300.00K derived: sum of 3 quarters · filed 2020-05-28 | $500.00K 10-K · filed 2020-05-28 | ||||
| 2018-12-31 | $100.00K 10-Q · filed 2020-02-10 | $200.00K derived: sum of 2 quarters · filed 2020-02-10 | $400.00K 10-Q · filed 2020-02-10 | $600.00K derived: sum of 4 quarters · filed 2020-02-10 | ||||
| 2018-09-30 | $100.00K 10-Q · filed 2019-11-07 | $200.00K 10-Q · filed 2019-11-07 | $500.00K derived: sum of 3 quarters · filed 2019-11-07 | $700.00K derived: sum of 4 quarters · filed 2019-11-07 | ||||
| 2018-06-30 | $100.00K 10-Q · filed 2019-08-08 | $400.00K derived: sum of 2 quarters · filed 2019-08-08 | $600.00K derived: sum of 3 quarters · filed 2019-08-08 | $900.00K derived: sum of 4 quarters · filed 2019-08-08 | ||||
| 2018-03-31 | $300.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-06-03 | $500.00K derived: sum of 2 quarters · filed 2019-06-03 | $800.00K derived: sum of 3 quarters · filed 2019-06-03 | $1.00M 10-K · filed 2019-06-03 | $1.03M 10-K · filed 2018-05-31 | |||
| 2017-12-31 | $200.00K 10-Q · filed 2019-02-07 | $192.00K 10-Q · filed 2018-02-08 | $500.00K derived: sum of 2 quarters · filed 2019-02-07 | $700.00K 10-Q · filed 2019-02-07 | $747.00K 10-Q · filed 2018-02-08 | $983.00K derived: sum of 4 quarters · filed 2019-02-07 | ||
| 2017-09-30 | $300.00K 10-Q · filed 2018-11-08 | $254.00K 10-Q · filed 2017-11-09 | $600.00K 10-Q · filed 2018-11-08 | $555.00K 10-Q · filed 2017-11-09 | $783.00K derived: sum of 3 quarters · filed 2018-11-08 | $995.00K derived: sum of 4 quarters · filed 2018-11-08 | ||
| 2017-06-30 | $300.00K 10-Q · filed 2018-08-09 | $301.00K 10-Q · filed 2017-08-09 | $483.00K derived: sum of 2 quarters · filed 2018-08-09 | $695.00K derived: sum of 3 quarters · filed 2018-08-09 | $1.09M derived: sum of 4 quarters · filed 2018-08-09 | |||
| 2017-03-31 | $183.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-05-31 | $395.00K derived: sum of 2 quarters · filed 2018-05-31 | $788.00K derived: sum of 3 quarters · filed 2018-05-31 | $956.00K 10-K · filed 2018-05-31 | ||||
| 2016-12-31 | $212.00K 10-Q · filed 2018-02-08 | $605.00K derived: sum of 2 quarters · filed 2018-02-08 | $773.00K 10-Q · filed 2018-02-08 | $773.00K derived: sum of 4 quarters · filed 2018-05-31 | ||||
| 2016-09-30 | $393.00K 10-Q · filed 2017-11-09 | $561.00K 10-Q · filed 2017-11-09 | $561.00K derived: sum of 3 quarters · filed 2018-05-31 | $561.00K derived: sum of 4 quarters · filed 2018-05-31 | ||||
| 2016-06-30 | $168.00K 10-Q · filed 2017-08-09 | $168.00K derived: sum of 2 quarters · filed 2018-05-31 | $168.00K derived: sum of 3 quarters · filed 2018-05-31 | $168.00K derived: sum of 4 quarters · filed 2018-05-31 | ||||
| 2016-03-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-05-31 | $0.00 derived: sum of 2 quarters · filed 2018-05-31 | $0.00 derived: sum of 3 quarters · filed 2018-05-31 | $0.00 10-K · filed 2018-05-31 | ||||
| 2015-12-31 | $0.00 10-Q · filed 2017-02-09 | $0.00 derived: sum of 2 quarters · filed 2017-02-09 | $0.00 10-Q · filed 2017-02-09 | |||||
| 2015-09-30 | $0.00 10-Q · filed 2016-11-03 | $0.00 10-Q · filed 2016-11-03 | ||||||
| 2015-06-30 | $0.00 10-Q · filed 2016-08-04 | |||||||
| 2015-03-31 | $0.00 10-K · filed 2017-06-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| Silexion Therapeutics Corp (SLXN) | $0.001B | ||
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |